Clinical Trials Logo

Philadelphia Positive clinical trials

View clinical trials related to Philadelphia Positive.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02448095 Terminated - Clinical trials for Chronic Myeloid Leukemia

Retrospective Evaluation of CML Patients in the National Compassionate Program

Start date: December 22, 2015
Phase:
Study type: Observational

This observational study aims at assessing the tolerability and safety profiles of Ponatinib, a drug used for Chronic Myeloid Leukemia patients who are Philadelphia positive. This drug is used during the chronic phase of the disease, according to the Italian national compassionate law 648/96.